家族性腺瘤性息肉病
Familial adenomatous polyposis
定义 英文原文(暂无中文)
A rare intestinal polyposis syndrome characterized by the development of up to hundreds to thousands of adenomas in the large bowel. It is a multi-system disorder with important extracolonic manifestations.
别名
结直肠腺瘤性息肉病
基本事实
- 遗传方式
- 常染色体显性、常染色体隐性
- 发病年龄
- 成年期
- 患病率
- 1-9 / 100 000
相关基因 1
| 基因 | 名称 | 关联类型 |
|---|---|---|
| APC | APC regulator of Wnt signaling pathway | Disease-causing germline mutation(s) in |
临床表型 45
极常见 99–80%6
- 腺瘤性结肠息肉病 HP:0005227
- 结肠癌 HP:0003003
- 结直肠息肉病 HP:0200063
- 先天性视网膜色素上皮肥大 HP:0007649
- 胃肠道硬纤维瘤 HP:0100245
- 胃肠道新生物 HP:0007378
常见 79–30%7
- 牙列异常 HP:0000164
- 便秘 HP:0002019
- 腹泻 HP:0002014
- 十二指肠息肉 HP:0004783
- 多发性胃息肉 HP:0004394
- 骨瘤 HP:0100246
- 甲状腺结节 HP:0025388
偶见 29–5%10
- 牙骨质形态异常 HP:0100717
- 甲状腺异常 HP:0000820
- 肾上腺皮质腺瘤 HP:0008256
- 血管纤维瘤 HP:0010615
- 十二指肠腺癌 HP:0006771
- 肾上腺肿瘤 HP:0100631
- 牙瘤 HP:0011068
- 甲状腺乳头状癌 HP:0002895
- 多生牙 HP:0011069
- 牙萌出失败 HP:0000706
罕见 <4–1%22
- 小肠腺癌 HP:0040274
- 星形细胞瘤 HP:0009592
- 胆道梗阻 HP:0005230
- 脑肿瘤 HP:0030692
- 胆管癌 HP:0030153
- 室管膜瘤 HP:0002888
- 表皮样囊肿 HP:0200040
- 纤维瘤 HP:0010614
- 甲状腺肿 HP:0000853
- 肝母细胞瘤 HP:0002884
- 甲状腺功能减退症 HP:0000821
- 脂肪瘤 HP:0012032
- 局限性皮损 HP:0011355
- 髓母细胞瘤 HP:0002885
- 胆囊新生物 HP:0100575
- 胰腺腺癌 HP:0006725
- 胰腺炎 HP:0001733
- 毛母质瘤 HP:0030434
- 垂体腺瘤 HP:0002893
- 软组织肿瘤 HP:0031459
- 胃癌 HP:0012126
- 甲状腺炎 HP:0100646
近两年的全球研究 2,073L2
2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-08综述Endoscopic Papillectomy for Ampullary Tumors in Older Patients: Balancing Oncologic Benefit and Geriatric Risk
- 2026-08综述Anatomical, physiological, and luminal adaptations occurring in an ileoanal pouch: opportunities for improving outcomes
- 2026-08Phase II Trial of Encapsulated Rapamycin to Reduce Polyp Burden Associated with Familial Adenomatous Polyposis
- 2026-08Positive Predictive Value of Symptoms for Early-Onset Colorectal Cancer
- 2026-07综述Differentiating Sporadic and Familial Adenomatous Polyposis-Associated Congenital Hypertrophy of the Retinal Pigment Epithelium From Congenital Grouped Pigmentation: A Review of Morphologic, Histopathologic, and Multimodal Imaging
- 2026-07Routine duodenal papillary biopsy enhances detection of duodenal papillary adenoma in familial adenomatous polyposis patients: a prospective cohort study
- 2026-07Molecular and immunohistochemical characterization of cribriform-morular thyroid carcinoma: insights into its origin and therapeutic targets
- 2026-07综述APC alterations in papillary thyroid carcinoma: molecular mechanisms, clinical implications, and future perspective
- 2026-07Locally Aggressive Desmoid Tumor With L4-L5 Vertebral Invasion and Progressive Neurological Deficit: A Case Report
- 2026-07Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones
- 2026-07Clinical and genetic features of pediatric hereditary polyposis syndromes in Israel: A nationwide multicenter cohort
- 2026-07Progressive intestinal tumor cell plasticity, Myc activation, and loss of Lgr5<sup>+</sup> tumor stem cell lineage commitment upon Wnt depletion
- 2026-07综述Pediatric Hereditary Polyposis Syndromes: Diagnosis, Surveillance, and Management Across Evolving Guidelines
- 2026-07Cribriform Morular Thyroid Carcinoma: Unreported Cytological Features With Histologic Correlation and Diagnostic Lessons From a Case Lacking Morules
- 2026-07综述Surgical Treatment and Postoperative Surveillance for Familial Adenomatous Polyposis
- 2026-07Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines
- 2026-07RETINAL PIGMENT EPITHELIAL TUMORS IN 948 EYES OF 926 PATIENTS
- 2026-07随机对照试验开放获取Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery: The ENRICH-US Stepped-Wedge Cluster-Randomized Trial
- 2026-07Multiple hybrid pilomatrical/epidermoid cysts with differential nuclear expression of β-catenin as a presenting symptom of familial adenomatous polyposis
- 2026-06Evaluation of ACMG/AMP guidelines for classifying APC variants in Korean patients with suspected familial adenomatous polyposis
境外已获批用于本病的药物 0L2
欧盟与美国均未检索到已获批用于本病的药物。
已获孤儿药资格、尚未获批的在研药物(17 项)
孤儿药资格只是一种监管身份——它意味着监管机构认可这是罕见病用药并给予研发激励,不代表这个药已被证明有效,也不代表将来一定能上市。绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。
- Eicosapentaenoic acid欧盟2009-10-08Treatment of familial adenomatous polyposis (FAP)官方记录
- eflornithine欧盟2010-09-20Treatment of familial adenomatous polyposis (FAP)官方记录
- (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-欧盟2022-07-18Treatment of familial adenomatous polyposis (FAP)官方记录
- Lithium carbonate欧盟2022-08-10Treatment of familial adenomatous polyposis (FAP)官方记录
- sirolimus欧盟2025-04-16Treatment of familial adenomatous polyposis (FAP)官方记录
- live attenuated E. Coli expressing Beta catenin shRNA美国2010-12-20Treatment of Familial Adenomatous Polyposis官方记录
- eflornithine美国2011-02-04Treatment of Familial Adenomatous Polyposis官方记录
- eicosapentaenoic acid美国2011-03-08Treatment of familial adenomatous polyposis官方记录
- eflornithine plus sulindac美国2013-01-22Treatment of familial adenomatous polyposis官方记录
- pyrvinium美国2015-01-05Treatment of familial adenomatous polyposis官方记录
- magnesium lysinate bis eicosapentaenoate美国2015-12-23Treatment of familial adenomatous polyposis.官方记录
- encapsulated rapamycin美国2019-03-15Treatment of familial adenomatous polyposis官方记录
- 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]美国2021-09-28Treatment of familial adenomatous polyposis官方记录
- Microencapsulated Interleukin-10美国2023-09-05Treatment of Familial Adenomatous Polyposis官方记录
- beta-catenin antagonist美国2024-12-10treatment of familial adenomatous polyposis官方记录
- selective dual antagonist of the human prostaglandin E2 (PGE2) recepto美国2025-03-31treatment of familial adenomatous polyposis (FAP)官方记录
- potent, ATP-competitive small molecule inhibitor of glycogen synthase 美国2026-05-22treatment of familial adenomatous polyposis官方记录
数据来自欧洲药品管理局(EMA)的药品与孤儿药资格公开导出表,以及美国 FDA 孤儿药资格数据库。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。
在中国开展的临床试验 4L2
按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。
登记为可入组 2
- 尚未开始招募NCT04531930Colorectal Adenoma Canceration in FAP中国研究中心 1 个:Shanghai
- 仅邀请入组NCT06649825Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.中国研究中心 1 个:Shanghai
其他状态的试验(2 项)
- 已完成NCT03333265Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride中国研究中心 1 个:Xi'an
- 已完成NCT05687318A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment中国研究中心 1 个:Beijing
中国境外的在招试验 23L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
CT.gov 报告命中 23 项,此处取回并展示最近的 15 项。
- 尚未开始招募NCT07729371A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
- 尚未开始招募NCT06308445Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis法国
- 招募中NCT07726771Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)英国
- 招募中NCT06641310Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)美国
- 尚未开始招募NCT06881303Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion法国
- 招募中NCT07463599Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma美国
- 招募中NCT05630794Testing for Safety and Colorectal Cancer Preventive Effects of ONC201美国
- 招募中NCT06950385Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis丹麦、德国、意大利、荷兰、Puerto Rico、西班牙、美国
- 招募中NCT06538402Ten Versus Fifteen Centimeter Pouch in IPAA Surgery丹麦
- 招募中NCT07066046Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions巴西
- 招募中NCT06614738Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)法国
- 招募中NCT06578637Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis美国
- 招募中NCT06545526Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis韩国
- 招募中NCT05552755Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)美国
- 招募中NCT05919264FOG-001 in Locally Advanced or Metastatic Solid Tumors澳大利亚、美国
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)